Investigation Alert FIGS, FRSH, ET, UPST: Johnson Fistel,
SAN DIEGO, Jan. 28, 2023 (GLOBE NEWSWIRE) -- FIGS, Inc. (NYSE: FIGS) Johnson Fistel, LLP is investigating potential
Globe Newswire28-01-2023, 22:14
Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis 26-02-2024, 14:05